John A. Skolas

John A. Skolas

Geen lopende functies

71 jaar
Consumer Services
Health Technology

Profiel

John A.
Skolas
was promoted to Executive Vice President, Chief Financial Officer, General Counsel and Secretary in July 2004.
Prior to that, he had served as our Senior Vice President, Chief Financial Officer, General Counsel and Secretary since October 2003.
Prior to that, He served as a consultant and acting chief financial officer for early stage biotechnology companies.
From 2000 through 2001, Mr. Skolas was Chief Financial Officer of Valigen, a privately held genomics company.
From 1999 through 2000, He served as Chief Financial Officer of Coelacanth Corporation (now the pharmaceuticals division of Lexicon Genetics).
From 1997 until 1999, He served as Chief Financial Officer and General Counsel of Phytoworks, Inc. From 1988 until 1997, He also served in various executive positions with EMI Group, PLC, including five years as President and General Counsel of its subsidiary EMI Group Inc. His early career included law practice as a partner in Muchin, Muchin, Bendix & Skolas S.C.
and accounting practice as a Tax Specialist for Coopers & Lybrand, CPA.
Mr. Skolas obtained a CPA certificate from the State of Iowa in 1976.
He earned an MBA from Harvard Business School in 1988 and a JD from the University of Wisconsin in 1977.

Eerdere bekende functies van John A. Skolas

BedrijvenFunctieEinde
Financieel Directeur/CFO 01-05-2007
Ervaring van John A. Skolas in detail bekijken

Opleiding van John A. Skolas

Harvard University Masters Business Admin
University of Wisconsin Undergraduate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van John A. Skolas in detail bekijken

Connecties

100 +

Eerstegraads connecties

3

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Bedrijven in privébezit1

Health Technology

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. John A. Skolas
-40 % Aanbod van beperkte duur: onze abonnementen leiden je naar de beste beleggingen van morgen.
PROFITEER NU